Enveda · 11 hours ago
Development and Translational AI Innovation Director
Enveda is a company focused on transforming natural compounds into life-changing medicines. As a Development and Translational AI Innovation Director, you will lead the integration of AI and machine-learning approaches across development and translational sciences to enhance drug discovery and clinical strategies.
BiotechnologyPharmaceuticalTherapeutics
Responsibilities
Lead the integration of AI and machine-learning approaches across Enveda’s development and translational sciences
Design and execute AI-driven strategies for preclinical, clinical and translational research
Collaborate with Drug and Clinical Development, Translational Science, Computational Biology, and Data science teams
Evaluate and implement state-of-the-art AI/ML methodologies for translational and clinical use cases
Develop strategic partnerships and translate scientific needs into scalable AI tools
Qualification
Required
Expertise in AI/ML applied to translational science, drug development including clinical development, and precision medicine
A track record of delivering impact with AI-enabled solutions in biotech, pharma, or health-tech
A systems-level thinker who can navigate ambiguity and connect dots communicating across disciplines
A collaborative partner who thrives in fast-moving, cross-functional environments
A relevant Bachelor's or Master's degree with applied experience deploying AI models and familiarity with regulatory considerations
Benefits
90% Medical, Dental, Vision
401k Match
Flexible PTO
Adoption Assistance
Company
Enveda
Enveda is a biotechnology company that is learning from life’s chemistry to create better medicines faster.
H1B Sponsorship
Enveda has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (2)
2024 (2)
2023 (1)
2022 (5)
Funding
Current Stage
Late StageTotal Funding
$529.9MKey Investors
Premji InvestSanofiKinnevik
2025-09-04Series D· $150M
2025-02-26Series C· $20M
2024-11-21Series C· $130M
Recent News
2026-01-06
Company data provided by crunchbase